Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: A 10-year retrospective study in a French region (Brittany)

被引:70
作者
Siret, D
Bretaudeau, G
Branger, B
Dabadie, A
Dagorne, M
David, V
de Braekeleer, M
Moisan-Petit, V
Picherot, G
Rault, G
Storni, V
Roussey, M
机构
[1] Ctr Hosp Gen, Serv Pediat, F-44600 St Nazaire, France
[2] CHU Nantes, Hop Mere & Enfant, Clin Med Pediat, F-44035 Nantes 01, France
[3] CHU, Ctr Soins Mucoviscidose, Rennes, France
[4] CHU, Ctr Reg Depistage Neonatal, Rennes, France
[5] CHU, Serv Epidemiol & Hyg Hosp, Rennes, France
[6] Ctr Hosp Gen, Serv Pediat, St Brieuc, France
[7] CHU Brest, Lab Cytogenet, F-29285 Brest, France
[8] Ctr Hosp Gen, Serv Pediat, Vannes, France
[9] Ctr Soins Mucoviscidose, Roscoff, France
关键词
cystic fibrosis; neonatal screening;
D O I
10.1002/ppul.10259
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Until the year 2000, systematic cystic fibrosis (CF) neonatal screening was only performed in a few regions of France. The Brittany region began in 1989, but not the neighboring region of Loire-Atlantique. The present study compares the clinical evolution of both affected populations 10 years after screening was started. Although the 77 screened and 36 nonscreened children were followed in different CF centers, they were included in similar care protocols. The clinical characteristics at diagnosis and their evolution over a 10-year period of all the children affected with CF and born between January 1, 1989 and December 31, 1998, excluding those with meconium ileus, were compared. There were no significant differences in sex ratio, gestational age, anthropometric data at birth, frequency of DeltaF508 homozygotes, proportion of pancreatic-insufficient patients, and mean age between the two populations. Age at diagnosis was lower in the screened group (38 days vs. 472 days, P < 10(-7)), as was the delay in supplementation with pancreatic enzymes (1.7 months vs. 15.9 months, P < 10(-7)). The proportion of children who were hospitalized at least once was higher among the nonscreened than the screened patients (86% vs. 49%, P < 10(-4)). Z-scores for weight and height were significantly better in the screened population, not only in the first years of life, but also at 5 years old for height and 8 years old for weight. The Shwachman and Brasfield scores were higher among the screened children during the whole period of follow-up. No significant differences in colonization by Pseudomonas aeruginosa nor in lung function were found. Given the homogeneity in the characteristics and the follow-up of both populations, the benefits in terms of nutrition and clinical well-being of neonatal screening appear to be clear, thus confirming the advantages of its general implementation.
引用
收藏
页码:342 / 349
页数:8
相关论文
共 30 条
[1]  
Ad Hoc Committee Task Force on Neonatal Screening, 1983, PEDIATRICS, V72, P741
[2]   THE RELATIONSHIP BETWEEN INFECTION AND INFLAMMATION IN THE EARLY STAGES OF LUNG-DISEASE FROM CYSTIC-FIBROSIS [J].
BALOUGH, K ;
MCCUBBIN, M ;
WEINBERGER, M ;
SMITS, W ;
AHRENS, R ;
FICK, R .
PEDIATRIC PULMONOLOGY, 1995, 20 (02) :63-70
[3]   NEONATAL SCREENING FOR CYSTIC-FIBROSIS [J].
BOWLING, F ;
CLEGHORN, G ;
CHESTER, A ;
CURRAN, J ;
GRIFFIN, B ;
PRADO, J ;
FRANCIS, P ;
SHEPHERD, R .
ARCHIVES OF DISEASE IN CHILDHOOD, 1988, 63 (02) :196-198
[4]   NEONATAL SCREENING FOR CYSTIC-FIBROSIS IN WALES AND THE WEST MIDLANDS - CLINICAL-ASSESSMENT AFTER 5 YEARS OF SCREENING [J].
CHATFIELD, S ;
OWEN, G ;
RYLEY, HC ;
WILLIAMS, J ;
ALFAHAM, M ;
GOODCHILD, MC ;
WELLER, P .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1991, 66 (01) :29-33
[5]   Normal growth in cystic fibrosis associated with a specialised centre [J].
Collins, CE ;
MacDonald-Wicks, L ;
Rowe, S ;
O'Loughlin, EV ;
Henry, RL .
ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 81 (03) :241-246
[6]   SURVIVAL AND CLINICAL OUTCOME IN PATIENTS WITH CYSTIC-FIBROSIS, WITH OR WITHOUT NEONATAL SCREENING [J].
DANKERTROELSE, JE ;
MEERMAN, GJT ;
MARTIJN, A ;
TENKATE, LP ;
KNOL, K .
JOURNAL OF PEDIATRICS, 1989, 114 (03) :362-367
[7]   SCREENING FOR CYSTIC-FIBROSIS - A COMPARATIVE-STUDY [J].
DANKERTROELSE, JE ;
MEERMAN, GJT ;
MARTIJN, A ;
TENKATE, LP ;
KNOL, K .
ACTA PAEDIATRICA SCANDINAVICA, 1987, 76 (02) :209-214
[8]   LONG-TERM PROGNOSIS OF PATIENTS WITH CYSTIC-FIBROSIS IN RELATION TO EARLY DETECTION BY NEONATAL SCREENING AND TREATMENT IN A CYSTIC-FIBROSIS CENTER [J].
DANKERTROELSE, JE ;
MEERMAN, GJT .
THORAX, 1995, 50 (07) :712-718
[9]  
*EUR RESP SOC, 1993, EUR RESPIR J, V16, P1
[10]  
FARRELL P, 2002, J CYSTIC FIBROSIS, V1, P16